Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

M Cynthia Butitta


  • Director at Urogen Pharma Ltd. (URGN), 2019-06-05
  • Chief Operating Officer at Kite Pharma Inc. (KITE), 2017-10-06
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KITE $179.66 4,228 Officer 121,567 2017-09-25 Filing
KITE $121.03 5,800 Officer 117,795 2017-08-10 Filing
KITE $120.52 9,200 Officer 123,595 2017-08-10 Filing
KITE $105.50 5,000 Officer 117,795 2017-07-10 Filing
KITE $102.81 1,100 Officer 122,795 2017-07-10 Filing